Skip to content
drillr.ai
Sign up

ANRO

Alto Neuroscience, Inc.

NYSE · Healthcare · Biotechnology · US

$35.55
−2.34%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue—————
Cost of Revenue184.0K661.0K502.0K—342.0K
Gross Profit(184.0K)(661.0K)(502.0K)—(342.0K)
Operating Expenses
R&D Expense64.9M45.6M47.0M30.3M23.7M
SG&A Expense23.4M20.7M21.6M7.5M5.2M
General & Admin Expense23.4M20.7M21.6M7.5M5.5M
Selling & Marketing Expense————(342.0K)
Other Expenses(132.9M)(661.0K)(502.0K)——
Total Operating Expenses(44.6M)65.7M68.1M37.8M28.9M
Cost and Expenses(44.5M)66.4M68.6M37.8M29.2M
Operating Income (EBIT)44.5M(66.4M)(68.6M)(37.8M)(29.2M)
Non-Operating
Interest Income6.8M6.6M8.9M2.3M114.0K
Interest Expense2.3M2.5M(1.4M)1.4M—
Net Interest Income4.5M4.1M10.2M979.0K114.0K
Other Non-Op Income/Expense(128.7M)3.1M7.2M1.5M1.5M
Non-Operating Income (excl Interest)126.4M(5.6M)(5.8M)(2.9M)(1.5M)
EBT (Pre-Tax Income)(84.2M)(63.2M)(61.4M)(36.3M)(27.7M)
Income Tax Expense—————
Bottom Line
Net Income(84.2M)(63.2M)(61.4M)(36.3M)(27.7M)
Earnings from Cont. Ops(84.2M)(63.2M)(61.4M)(36.3M)(27.7M)
Earnings from Discont. Ops—————
Bottom Line Net Income(84.2M)(63.2M)(61.4M)(36.3M)(27.7M)
Per Share
Basic EPS($2.48)($2.19)($2.50)($1.35)($1.08)
Diluted EPS($2.48)($2.19)($2.50)($1.35)($1.08)
Revenue Per Share$0.00$0.00$0.00$0.00$0.00
Shares
Basic Shares Outstanding42.8M28.9M24.6M26.9M25.6M
Diluted Shares Outstanding42.8M28.9M24.6M26.9M25.6M
Profitability Metrics
EBITDA(81.5M)(60.1M)(62.3M)(34.6M)(27.4M)
D&A505.0K661.0K502.0K373.0K342.0K
EBIT(82.0M)(60.8M)(62.8M)(34.9M)(27.7M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026